The purpose of this study was to examine the role of Keap1-Nrf2 signaling in the pathophysiology of depression using the potent Nrf2 activator, SFN and Nrf2 knock-out (KO) mice. This evidence concerns the gene NFE2L2 and major depressive disorder.